| Item | Amount | Y/Y |
|---|---|---|
| Revenue | $1.59B | +7.3% |
| Gross profit | $0.70B | — |
| Operating income | $0.32B | — |
| Net income | $0.22B | +51.2% |
| Gross margin | 43.9% | Net margin 13.9% |
| Revenue Q/Q | +6.2% | — |
| Segment | Revenue | Share |
|---|---|---|
| Healthcare | $1.14B | 71.5% |
| AST | $0.29B | 18.2% |
| Life Sciences | $0.16B | 10.3% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | $0.89B | 56.1% |
| R&D | $0.03B | 1.8% |
| SG&A | $0.35B | 22.1% |
| Tax & other | $0.10B | 6.1% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
SYK ・ SMCI ・ SYF ・ SNPS ・ SYY ・ TMUS ・ TROW ・ TTWO ・ TPR ・ TRGP ・ TGT ・ TEL
Source: SEC EDGAR · This page shows public filing data only, not investment advice. · Browse all companies